Scientific Programme - Main Sessions

Advances in techniques to delineate the epileptogenic zone
Christoph Baumgartner (Austria)  / Andreas  Schulze-Bonhage (Germany), Chairs

Hemodynamic correlates of epileptic activity using fMRI and their potential clinical role
Louis Lemieux (UK)

Spectroscopic imaging in presurgical evaluation of  epilepsy patients
Pavel Krsek (Czech Republic)

Approaches to focus localization using modern PET tracers
Philippe Ryvlin (France)

Identification of superficial and deep sources of epileptic activity by magnetoencephalography
Andreas Ioannides (Cyprus)

From single cell  recordings to high  frequency oscillations: novel  indicators of  epileptogenicity
Julia Jacobs (Germany)

AED development, selection and use relevant to gender and age
Martin Brodie (UK)  / Torbjorn Tomson (Sweden), Chairs

Clinical Trials of  AEDs: new  EMEA guidelines vs. clinical needs in different age groups
Michel Baulac (France)

Towards a syndrome-based AED selection in children
Thanos Covanis  (Greece)

AED selection and use in women of  childbearing potential
Jim Morrow (UK)

AED selection and use in the  elderly: pharmacodynamic and pharmacokinetic considerations
Emilio Perucca (Italy)

Idiosyncratic adverse effects: are they age-dependent and if so  why?
Munir Pirmohamed (UK)

Challenging the concept of idiopathic epilepsies
Michalis Koutroumanidis (UK), Chair

Clinical EEG (ictal – interictal) evidence
Renzo Guerrini (Italy)

Evidence from  analysis of  clinical seizures and interictal findings with advanced neurophysiological and neuroimaging techniques
Vasilios K. Kimiskidis (Greece)

Mechanisms of their dependence on arousal level
Peter Halasz (Hungary)

In search of  a satisfactory terminology (taxonomic implications)
Peter Wolf (Denmark)

Predicting epileptogenesis: how far are we from reaching the goal?
Marco de Curtis (Italy), Chair

Predictors and biomarkers, definitions and general concepts
Simon Shorvon (UK)

Neurobiological markers of epileptogenesis
Asla Pitkanen (Finland)

Practical benefits of  predicting epileptogenesis: when  and how biomarkers can  be helpful
Jerome  Engel (USA)

Biological and clinical predictors of pharmacoresistance
Yitzak Schiller (Israel)